Insulin sensitizers for polycystic ovary syndrome

Clin Obstet Gynecol. 2003 Jun;46(2):325-40. doi: 10.1097/00003081-200306000-00011.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Chromans / adverse effects
  • Chromans / therapeutic use
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Metformin / adverse effects
  • Metformin / therapeutic use
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / drug therapy*
  • Randomized Controlled Trials as Topic
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Metformin
  • Troglitazone